Literature DB >> 25268575

Structural and mechanistic insights into NDM-1 catalyzed hydrolysis of cephalosporins.

Han Feng1, Jingjin Ding, Deyu Zhu, Xuehui Liu, Xueyong Xu, Ying Zhang, Shanshan Zang, Da-Cheng Wang, Wei Liu.   

Abstract

Cephalosporins constitute a large class of β-lactam antibiotics clinically used as antimicrobial drugs. New Dehli metallo-β-lactamase (NDM-1) poses a global threat to human health as it confers on bacterial pathogen resistance to almost all β-lactams, including penicillins, cephalosporins, and carbapenems. Here we report the first crystal structures of NDM-1 in complex with cefuroxime and cephalexin, as well as NMR spectra monitoring cefuroxime and cefixime hydrolysis catalyzed by NDM-1. Surprisingly, cephalosporoate intermediates were captured in both crystal structures determined at 1.3 and 2.0 Å. These results provide detailed information concerning the mechanism and pathways of cephalosporin hydrolysis. We also present the crystal structure and enzyme assays of a D124N mutant, which reveals that D124 most likely plays a more structural than catalytic role.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25268575     DOI: 10.1021/ja508388e

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  39 in total

1.  Role of Non-Active-Site Residue Trp-93 in the Function and Stability of New Delhi Metallo-β-Lactamase 1.

Authors:  Asad U Khan; M Tabish Rehman
Journal:  Antimicrob Agents Chemother       Date:  2015-11-02       Impact factor: 5.191

2.  Structural Insights into Recognition of Hydrolyzed Carbapenems and Inhibitors by Subclass B3 Metallo-β-Lactamase SMB-1.

Authors:  Jun-Ichi Wachino; Yoshihiro Yamaguchi; Shigetarou Mori; Wanchun Jin; Kouji Kimura; Hiromasa Kurosaki; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

Review 3.  A close look onto structural models and primary ligands of metallo-β-lactamases.

Authors:  Joanna E Raczynska; Ivan G Shabalin; Wladek Minor; Alexander Wlodawer; Mariusz Jaskolski
Journal:  Drug Resist Updat       Date:  2018-08-25       Impact factor: 18.500

Review 4.  Overcoming differences: The catalytic mechanism of metallo-β-lactamases.

Authors:  María-Rocío Meini; Leticia I Llarrull; Alejandro J Vila
Journal:  FEBS Lett       Date:  2015-08-20       Impact factor: 4.124

5.  Structural Insights into Inhibition of Escherichia coli Penicillin-binding Protein 1B.

Authors:  Dustin T King; Gregory A Wasney; Michael Nosella; Anita Fong; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2016-11-29       Impact factor: 5.157

6.  Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases.

Authors:  Orville A Pemberton; Priyadarshini Jaishankar; Afroza Akhtar; Jessie L Adams; Lindsey N Shaw; Adam R Renslo; Yu Chen
Journal:  J Med Chem       Date:  2019-09-13       Impact factor: 7.446

7.  Investigating the position of the hairpin loop in New Delhi metallo-β-lactamase, NDM-1, during catalysis and inhibitor binding.

Authors:  Mahesh Aitha; Abraham J Moller; Indra D Sahu; Masaki Horitani; David L Tierney; Michael W Crowder
Journal:  J Inorg Biochem       Date:  2015-10-22       Impact factor: 4.155

8.  Probing substrate binding to the metal binding sites in metallo-β-lactamase L1 during catalysis.

Authors:  Mahesh Aitha; Sameer Al-Adbul-Wahid; David L Tierney; Michael W Crowder
Journal:  Medchemcomm       Date:  2016-01-04       Impact factor: 3.597

Review 9.  B1-Metallo-β-Lactamases: Where Do We Stand?

Authors:  Maria F Mojica; Robert A Bonomo; Walter Fast
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

10.  Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase.

Authors:  Mariano M González; Magda Kosmopoulou; Maria F Mojica; Valerie Castillo; Philip Hinchliffe; Ilaria Pettinati; Jürgen Brem; Christopher J Schofield; Graciela Mahler; Robert A Bonomo; Leticia I Llarrull; James Spencer; Alejandro J Vila
Journal:  ACS Infect Dis       Date:  2015-07-20       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.